ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Walgreens Boots Alliance, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WBA

Core Viewpoint - A class action lawsuit has been filed against Walgreens Boots Alliance, Inc. for failing to disclose significant regulatory compliance issues during the Class Period from April 2, 2020, to January 16, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit alleges that Walgreens engaged in widespread violations of federal law regarding prescription medication dispensation and reimbursement [5]. - It claims that Walgreens' public statements were materially false and misleading, leading to investor damages when the truth was revealed [5]. - The lawsuit indicates that Walgreens' revenues from prescription sales were unsustainable due to unlawful conduct [5]. Group 2: Participation Information - Investors who purchased Walgreens common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly [3][6]. - A lead plaintiff must be appointed by March 31, 2025, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements for investors, including over $438 million in 2019 [4]. - The firm has been recognized for its leadership in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [4].